In Vitro Studies

 

Raptim Research Private Limited is a global independent and internationally accredited Contract Research Organization (CRO), established in 2005 with state-of-the-art clinical research facilities at Mumbai and Gandhinagar.

Raptim provides different types of In-vitro services
to demonstrate Bioequivalence.

Contact us for more details

Name*
Company Name*
E-Mail*
Phone
Comments

Raptim's Experience

1. In Vitro Release Test (IVRT) and In Vitro Permeation Test (IVPT) for topical products

IVRT Studies

  • Acyclovir Ointment
  • Diclofenac Gel
  • Lidocaine Gel
  • Nystatin & Triamcinolone Ointment
  • Nystatin Cream
  • Nystatin Ointment
  • Dapsone Gel 5% & 7.5%

IVPT Studies

  • Acyclovir Cream
  • Doxepin Cream
  • Diclofenac Gel
  • Dapsone gel
  • Tacrolimus
  • Penciclovir Cream

2. BCS Bio-waiver Studies

Bio-waiver studies using Caco2 cell Lines

  • Buspirone – 2 studies (Approved by USFDA – 3rd May 2018 and 16rd April 2019
  • Ramelteon (Approved by USFDA) 10th April 2020
  • Imatinib (2 studies)
  • Varenicline (3 studies)
  • Cyclophosphamide
  • Dexamphetamine
  • Levorphanol
  • Doxepin
  • Hydroxychloroquine
  • Pimavanserin
  • Brivaracetam

3. In Vitro Binding Studies (Phase 1 & 2)

  • Colesevelam Tablets and Colesevelam Suspension
  • Sevelamer Tablet and Sevelamer Suspension
  • Sucralfate suspension

4. In Vitro Feeding Tube Studies

  • Mycophenolate mofetil oral suspension
  • Lansoprazole delayed-release capsule
  • Dexlansoprazole delayer release capsule
  • Ticagrelor tablet